AzTrials
AzTrials

Acute PainMOLIVeRNCT07878117

MOLI Technique and Virtual Reality Versus Conventional Venipuncture for Pain and Anxiety in Children

A study testing Conventional venipuncture technique, MOLI technique and Meta Quest 3 with Fruit Ninja VR in people with Acute Pain and Anxiety, run by José Luis Cobo Sánchez at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Venipuncture is one of the most frequent and distressing invasive procedures in paediatric care. Both immersive virtual reality (VR) and structured breathing-based active distraction have been proposed as effective non-pharmacological strategies to reduce procedural pain and anxiety. Read more about this study

Who is it for?
Ages 4 to 12 years
Conditions the study is for
Acute Pain, Anxiety, Pain, Procedural
What is being tested?
Conventional venipuncture technique, MOLI technique and Meta Quest 3 with Fruit Ninja VR
Could I receive a placebo?
No, everyone receives an active treatment
How many people
201 participants
Where
1 siteSpain
Study dates
1 Nov 2024to 31 Aug 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 4 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Aged between 4 and 12 years.
  • Clinical indication for peripheral venous catheter insertion.
  • Triage priority III, IV or V in the Andorran Model of Triage - Spanish Triage System (MAT-SET), paediatric version.
  • Written informed consent from the parent or legal guardian, and age-appropriate assent from the child.

Who cannot join

  • Language barrier or physical condition preventing collaboration.
  • Clinical condition preventing the intervention (severe respiratory distress; Glasgow Coma Scale less than or equal to 14).
  • Sensory impairment to pain (e.g., spina bifida).
  • History of seizures or recurrent syncope.
  • Psychomotor or neurocognitive delay that would compromise anxiety assessment.
  • Visual or hearing impairment incompatible with the use of the virtual reality headset or with verbal communication.
  • Refusal to participate.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Hospital Universitario Marques de Valdecilla

    Santander, Cantabria, 39008

Other trials in Spain

About this study

Official title: Efficacy of the MOLI Technique and Virtual Reality Versus Conventional Venipuncture for Pain and Anxiety in Paediatric Patients: A Three-Arm Randomised Controlled Trial

Venipuncture is one of the most frequent and distressing invasive procedures in paediatric care. Both immersive virtual reality (VR) and structured breathing-based active distraction have been proposed as effective non-pharmacological strategies to reduce procedural pain and anxiety. However, no randomised controlled trial has directly compared a structured breathing-based intervention with immersive VR and with the conventional technique.

The MOLIVeR trial is a single-centre, parallel three-arm randomised controlled trial (1:1:1 allocation) that compared the MOLI technique (a Spanish acronym for movilizacion, observacion, ludica e inmersion, matching the English Mobilisation, Observation, Ludic engagement and Immersion; a pinwheel-guided active-distraction breathing protocol), immersive VR (Meta Quest 3, Fruit Ninja VR) and the conventional technique in children aged 4-12 years requiring peripheral venous catheter insertion in a tertiary university hospital in Spain. The primary outcomes were pain intensity (Faces Pain Scale-Revised) and procedural anxiety (Groningen Distress Scale), assessed immediately after catheter insertion. Secondary outcomes were pre and post-procedure heart rate, first-attempt insertion success, procedure duration and adverse events. Analyses followed the intention-to-treat principle.

Read the detailed description

Study design. Single-centre, parallel three-arm randomised controlled trial with 1:1:1 allocation, without blinding of participants or study personnel, and analysed under the intention-to-treat principle. Designed and reported in accordance with the CONSORT 2025 guidelines for parallel-group randomised trials and the TIDieR checklist for intervention description.

Setting and sample size. Conducted between 1 November 2024 and 31 August 2025 in the paediatric emergency department, paediatric short-stay unit and paediatric inpatient ward of a tertiary university hospital in northern Spain. Sample size was calculated using the GRANMO calculator to detect a between-group difference in pain intensity of at least 1 point (Faces Pain Scale-Revised) with an expected standard deviation of 0.5 points, accepting a two-sided alpha of 0.05, 80% power, an anticipated dropout rate of 5%, and Bonferroni adjustment for multiple pairwise comparisons. A total of 201 children (67 per arm) were required.

Randomisation. A statistician independent of the clinical team generated the randomisation sequence using Epidat 4.2 with permuted blocks of variable size (6 and 9). Group identifiers were placed in sealed, opaque, sequentially numbered envelopes. Because of the nature of the interventions, blinding of participants, families and staff was not possible. Statistical analysis was performed by an investigator who had not participated in allocation or intervention delivery.

Interventions. All interventions were delivered by paediatric nurses trained in a preparatory session before the trial start. The MOLI technique combined standardised positioning on the caregiver's lap, playful reframing of clinical devices, a forced slow-expiration exercise using a paper pinwheel held by the caregiver, and visual concealment of the venipuncture material by an assistant nurse. The virtual reality arm used a Meta Quest 3 headset with the Fruit Ninja VR application (Classic mode); positioning and family involvement were identical to the MOLI arm, replacing the pinwheel with the headset. The conventional arm consisted of standardised positioning, gentle limb restraint by an assistant nurse and family emotional support, without any structured distraction technique.

Outcomes. Primary outcomes were pain intensity (Faces Pain Scale-Revised, 0-10) and procedural anxiety (Groningen Distress Scale, 1-5) assessed immediately after peripheral venous catheter insertion. Secondary outcomes were pre and post-procedure heart rate (bpm), first-attempt insertion success, procedure duration, successful blood sampling and adverse events attributable to each intervention.

Statistical analysis. Continuous variables were summarised as mean and standard deviation or median and interquartile range depending on distribution. Between-group comparisons used the Kruskal-Wallis test with epsilon squared as the effect-size measure. Post-hoc pairwise comparisons were performed with Mann-Whitney U tests using Bonferroni adjustment for three comparisons, reporting r as the effect-size measure. Categorical variables were compared with the Chi-square test. A pre-specified age-subgroup analysis (4-6, 7-9, 10-12 years) was performed for the primary outcomes. All tests were two-sided at the 5% level.

Being tested
Conventional venipuncture technique, MOLI technique, Meta Quest 3 with Fruit Ninja VR
Keywords
Paediatric nursing, Virtual reality, Distraction, Breathing exercises, Venipuncture, Peripheral venous catheter, Non-pharmacological pain management, Randomised controlled trial, Child
Medical subject headings
Acute Pain, Anxiety Disorders, Pain, Procedural

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Conventional venipuncture techniqueProcedure or surgery

    Standard-care venipuncture without structured distraction. Delivered by paediatric nurses of the participating units.

  • MOLI techniqueBehavioural

    Structured active-distraction protocol combining standardised positioning on the caregiver's lap, playful reframing of clinical devices (tourniquet as strength bracelet, pulse oximeter as red-light sticker), pinwheel-guided slow forced expiration held by the caregiver, and visual concealment of the venipuncture material by an assistant nurse. Delivered by paediatric nurses trained in a pre-trial standardisation session, with a supporting leaflet and demonstration videos.

  • Meta Quest 3 with Fruit Ninja VRDevice

    Immersive virtual reality distraction using a Meta Quest 3 standalone headset (Meta Platforms, Inc.) with the Fruit Ninja VR application (Halfbrick Studios) in Classic mode. Delivered together with the same caregiver positioning, playful reframing and visual concealment used in the MOLI arm.

Study groups in NCT07878117
Study groupRoleWhat they receive
Conventional Technique (CT)Active comparatorStandard-care venipuncture without any structured distraction technique. The child was placed supine on the trolley with the head end elevated to 30 degrees. An assistant nurse gently restrained the limbs. The caregiver was positioned next to the assistant on the opposite side from the nurse, providing emotional support without interfering in the working field. Heart rate was monitored by pulse oximetry before insertion.
Receives: Procedure: Conventional venipuncture technique
MOLI TechniqueExperimentalStructured active-distraction protocol combining positioning, visual concealment, playful reframing and pinwheel-guided breathing. In children up to 10 years the participant sat on the caregiver's lap; from 11 years the participant sat on the trolley. The nurse introduced the tourniquet ("strength bracelet") and the pulse oximeter ("red-light sticker") using a playful script. Immediately before skin antisepsis, the nurse handed a paper pinwheel to the caregiver, who held it 20-30 cm from the child's mouth. During insertion, the child was verbally prompted to "blow hard - spin the pinwheel" in a repeated fashion.
Receives: Behavioral: MOLI technique
Virtual Reality (VR)ExperimentalImmersive virtual reality distraction. A Meta Quest 3 standalone headset was used with the Fruit Ninja VR application (Classic mode) as active distraction during catheter insertion. Positioning of the child, assistant nurse and caregiver was identical to the MOLI arm, replacing the pinwheel with the headset. The child operated the controller with the arm contralateral to the venipuncture site and was encouraged to "slice the fruit" throughout catheter insertion.
Receives: Device: Meta Quest 3 with Fruit Ninja VR

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Procedural pain intensity

    Pain intensity measured with the Faces Pain Scale-Revised (FPS-R), a six-face pictorial self-report scale scored from 0 (no pain) to 10 (very much pain), validated for children aged 4-16 years.

    Measured: Immediately after peripheral venous catheter insertion (single assessment; approximately 1 minute after catheter fixation)

  2. Procedural anxiety

    Procedural anxiety assessed with the observer-rated Groningen Distress Scale, scored from 1 (calm) to 5 (panic) by an external observer.

    Measured: Immediately after peripheral venous catheter insertion (single assessment; approximately 1 minute after catheter fixation)

Secondary outcomes (5)
  1. First-attempt PVC insertion success

    Successful catheter insertion in the first attempt (yes/no).

    Measured: At the time of peripheral venous catheter insertion

  2. Duration of the venipuncture procedure

    Time (in minutes) from skin antisepsis to the fixation of the catheter dressing, measured by an external observer.

    Measured: From skin antisepsis to catheter dressing (typically less than 10 minutes)

  3. Change in heart rate (pre to post insertion)

    Difference between pre and post-procedure heart rate (bpm), measured with pulse oximetry.

    Measured: Immediately before and immediately after peripheral venous catheter insertion

  4. Successful blood sampling

    Successful collection of the required blood sample through the inserted catheter (yes/no).

    Measured: At the time of peripheral venous catheter insertion

  5. Adverse events attributable to the intervention

    Adverse events attributable to each intervention: motion sickness or visual discomfort in the VR arm; brief respiratory discomfort or vasovagal syncope in the MOLI arm; skin erythema or joint discomfort in the CT arm.

    Measured: During and immediately after the procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Oct 2026
  2. Study start1 Nov 2024
  3. Primary completion31 Aug 2025
  4. Study completion31 Aug 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
201 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07878117
Sponsor's protocol ID
MOLIVeR-2024.249
Other IDs
ENFVAL24/26, 2024.249
Acronym
MOLIVeR
Status last verified
Nov 2025
First submitted
21 Sep 2026
Last updated
16 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data are not planned to be shared publicly because of ethical constraints related to paediatric research participants. De-identified data may be made available from the corresponding author upon reasonable request and with the appropriate ethical approvals.

Questions about this trial

What is this clinical trial studying?

A study testing Conventional venipuncture technique, MOLI technique and Meta Quest 3 with Fruit Ninja VR in people with Acute Pain and Anxiety, run by José Luis Cobo Sánchez at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Procedural pain intensity (time frame: Immediately after peripheral venous catheter insertion (single assessment; approximately 1 minute after catheter fixation)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in